03/06/2014 - 09:22

Insomnia is associated with brain activity changes during wakefulness according to a new study. The results showed that the motor cortex of the brains of people with insomnia were surprisingly more neuroplastic- that is more adaptable to change and retraining- than those of good sleepers. This is despite association of insomnia with decreases in concentration and memory.


02/27/2012 - 09:28

New research from the University of Leicester demonstrates that physical symptoms may be indicative of depression in cancer patients. Bodily complaints such as fatigue, insomnia and poor appetite are known to be symptoms of depression in primary care but traditional teaching suggested that these so called somatic symptoms of depression should be ignored in medical settings where they are assumed to be contaminants of physical illness.

12/15/2011 - 11:00

A team from the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University has made a major breakthrough by unraveling the inner workings of melatonin, also known as the “sleep hormone.” The research, conducted in collaboration with scientists in Italy, reveals the key role played by the melatonin receptor in the brain that promotes deep, restorative sleep. This discovery led the researchers to develop a novel drug called UCM765, which selectively activates this receptor.

11/25/2011 - 20:08

The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep.